SCHEMBL482633

SCHEMBL482633

[O]C(Br)(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2422453 0.72
SCHEMBL269083 0.72
SCHEMBL2074346 0.72
SCHEMBL2218552 0.72
SCHEMBL2427349 0.72
SCHEMBL4306283 0.72
SCHEMBL10991808 0.72
SCHEMBL18243176 0.68
SCHEMBL4082985 0.68
SCHEMBL2401857 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 922 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116854683-A Coumarin thiazole derivative and preparation method and application thereof 中北大学 2023-10-10 CN claimed
CN-111018686-B 6-benzylidene-2-aryl ethynyl cyclohexenone derivative and preparation method and medical application thereof 南通大学 2020-09-22 CN claimed
CN-111560019-A Method for synthesizing isopentenyl adenine or derivatives thereof by one-step method 安徽京和生物药业科技有限公司 2020-08-21 CN claimed
CN-111018686-A 6-benzylidene-2-aryl ethynyl cyclohexenone derivative and preparation method and medical application thereof 南通大学 2020-04-17 CN claimed
WO-2019078246-A1 IDO/TDO INHIBITOR 一般社団法人ファルマバレープロジェクト支援機構 2019-04-25 WO claimed
EP-2395993-B1 SKIN TREATMENT LEO LABORATORIES LTD (IE) 2017-06-21 EP claimed
US-8084613-B2 Tetrazoyloxime derivative and plant disease control agent NIPPON SODA CO., LTD. (JP) 2011-12-27 US claimed
US-20050272036-A1 Ketones ASTRAZENECA AB (SE) 2005-12-08 US claimed
US-4622413-A ESTERIFICATION, SALT FORMATION PPG INDUSTRIES, INC. (US) 1986-11-11 US claimed
US-12043640-B2 Prodrugs of STAT3 inhibitors TVARDI THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
US-20240238460-A1 IMPROVED PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETING RADIOPHARMACEUTICALS AND USES THEREOF TELIX PHARMACEUTICALS INNOVATIONS PTY LTD (AU) 2024-07-18 US disclosed
WO-2024148932-A1 EGFR C797S MUTATION INHIBITOR AND PHARMACEUTICAL USE THEREOF 上海和誉生物医药科技有限公司 2024-07-18 WO disclosed
CN-117480164-B Factor XIa inhibitor and preparation method and application thereof 上海领泰生物医药科技有限公司 2024-07-05 CN disclosed
EP-4393922-A1 IRAK4 DEGRADATION AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-07-03 EP disclosed
EP-0110576-A2 Ionizing radiation-sensitive material and its use for preparing a pattern JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1984-06-13 EP disclosed
EP-0023584-B1 PROCESS FOR THE PREPARATION OF TRIFLUOROMETHYL NAPHTHALENES BAYER AG (DE) 1983-01-26 EP disclosed
US-4331613-A Process for the preparation of trifluoromethylnaphthalenes BAYER AKTIENGESELLSCHAFT (DE) 1982-05-25 US disclosed
EP-0008453-B1 PROCESS FOR PREPARING TRIFLUOROMETHYL AROMATIC COMPOUNDS BAYER AG (DE) 1981-04-29 EP disclosed
EP-0023584-A1 Process for the preparation of trifluoromethyl naphthalenes BAYER AG (DE) 1981-02-11 EP disclosed
EP-0008453-A1 Process for preparing trifluoromethyl aromatic compounds BAYER AG (DE) 1980-03-05 EP disclosed